Delivery Order SPE2DB20D3103-SPE2DB23FL9X2
Award Date 12/22/22
Potential Completion Date 12/23/22
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with an ID of SPE2DB20D3104|SPE2DB22FV6T9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.34 firm fixed-price delivery order is for the supply of 4,557,140 units of hydroxychloroquine 200mg tablets. The contract has an ultimate completion date of May 9, 2022 and was awarded on May 6, 2022. This award is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,984,356 units of hydroxychloroquine 200 mg tablets. The contract, valued at $1,539.32, is a firm fixed-price delivery order with an ultimate completion date of August 30, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,926.37 firm-fixed-price delivery order is for the supply of 4,559,118,916 units of 200 mg hydroxychloroquine tablets packaged in 100-count bottles. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of 4,560,256,895 units of hydroxychloroquine 200 mg tablets, priced at a firm fixed price of $2,766.59. The award was made on March 14, 2023, with a completion date of March 15, 2023, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated with any set-aside requirements, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,610.31 firm fixed price Delivery Order (SPE2DB23FV6G6) is for the supply of 4,560,694,177 units of Hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of April 25, 2023 and does not utilize any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
- This federal contract award, with identification number SPE2DB20D3103|SPE2DB22FP9K9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.32 firm fixed-price delivery order is for the supply of 4,558,528,321 units of hydroxychloroquine 200 mg tablets. The contract has a completion date of September 21, 2022 and was awarded on September 20, 2022. Amerisourcebergen, a for-profit...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,632.85 delivery order contract is for the supply of hydroxychloroquine 200 mg tablets. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hydroxychloroquine 200 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,408.15. The award date was March 28, 2022, with an ultimate completion date of March 29, 2022. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of hydroxychloroquine 200 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a parent company called Cencora, Inc. The contract has a ceiling value of $3,652.07 and was awarded on September 13, 2021, with a completion date of September 14, 2021. It is a firm fixed-price delivery order contract, with no set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $90,494.47 firm fixed-price delivery order is for the supply of 4,560,160,597 units of Plaquenil 200 mg tablets. The award has a performance period through March 7, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...